Pfizer BioNTech's approved by US regulators, ships to resume berthing at Ningbo, the outlook for cryptocurrencies, Visa and crypto punk, Chinese regulator halts 42 IPOs on probe of broker, SEC's updated requirements for US IPO Disclosures, Dividends for this year, DIDI, Microsoft, Chinese tech and HSI